Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ken Herrmann

Showing results (321-330 of 721) with videos related to

Pageof 73
Sort By:
BMC Cancer|April 19, 2014
Somatostatin receptor expression in Merkel cell carcinoma as target for molecular imagingKristina Buder, Constantin Lapa, Michael C Kreissl, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 16, 2014
Impact of 68Ga-DOTATATE PET/CT on the management of neuroendocrine tumors: the referring physician's perspectiveKen Herrmann, Johannes Czernin, Edward M Wolin, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 6, 2010
Cost-effectiveness of hybrid PET/CT for staging of non-small cell lung cancerJonas Schreyögg, Julia Weller, Tom Stargardt, et al.
Nuclear Medicine and Molecular Imaging|August 25, 2020
Assessment of Suspected Malignancy or Infection in Immunocompromised Patients After Solid Organ Transplantation by [<sup>18</sup>F]FDG PET/CT and [<sup>18</sup>F]FDG PET/MRINika Guberina, Anja Gäckler, Johannes Grueneisen, et al.
European Radiology|February 20, 2015
Evaluation of several FDG PET parameters for prediction of soft tissue tumour grade at primary diagnosis and recurrenceWolfgang P Fendler, Rebecca P Chalkidis, Harun Ilhan, et al.
Gastroenterology|April 3, 2012
Pan-histone deacetylase inhibitor panobinostat sensitizes gastric cancer cells to anthracyclines via induction of CITED2Ivonne Regel, Lisa Merkl, Teresa Friedrich, et al.
European Journal of Radiology|December 3, 2020
Correlation of the apparent diffusion coefficient (ADC) and standardized uptake values (SUV) with overall survival in patients with primary non-small cell lung cancer (NSCLC) using <sup>18</sup>F-FDG PET/MRINils Martin Bruckmann, Julian Kirchner, Johannes Grueneisen, et al.
Oncotargets and Therapy|June 13, 2014
Positron emission tomographic monitoring of dual phosphatidylinositol-3-kinase and mTOR inhibition in anaplastic large cell lymphomaNicolas Graf, Zhoulei Li, Ken Herrmann, et al.
EJNMMI Research|July 18, 2024
[<sup>68</sup>Ga]Ga-FAPI versus 2-[<sup>18</sup>F]FDG PET/CT in patients with autoimmune thyroiditis: a case control studyKim M Pabst, Lukas Kessler, Justin Ferdinandus, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 6, 2022
An EANM position paper on advancing radiobiology for shaping the future of nuclear medicine, Jean-Pierre Pouget, Mark Konijnenberg, et al.
Pageof 73

Showing results (321-330 of 721) with videos related to

Sort By:
Pageof 73
BMC Cancer|April 19, 2014
Somatostatin receptor expression in Merkel cell carcinoma as target for molecular imagingKristina Buder, Constantin Lapa, Michael C Kreissl, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 16, 2014
Impact of 68Ga-DOTATATE PET/CT on the management of neuroendocrine tumors: the referring physician's perspectiveKen Herrmann, Johannes Czernin, Edward M Wolin, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 6, 2010
Cost-effectiveness of hybrid PET/CT for staging of non-small cell lung cancerJonas Schreyögg, Julia Weller, Tom Stargardt, et al.
Nuclear Medicine and Molecular Imaging|August 25, 2020
Assessment of Suspected Malignancy or Infection in Immunocompromised Patients After Solid Organ Transplantation by [<sup>18</sup>F]FDG PET/CT and [<sup>18</sup>F]FDG PET/MRINika Guberina, Anja Gäckler, Johannes Grueneisen, et al.
European Radiology|February 20, 2015
Evaluation of several FDG PET parameters for prediction of soft tissue tumour grade at primary diagnosis and recurrenceWolfgang P Fendler, Rebecca P Chalkidis, Harun Ilhan, et al.
Gastroenterology|April 3, 2012
Pan-histone deacetylase inhibitor panobinostat sensitizes gastric cancer cells to anthracyclines via induction of CITED2Ivonne Regel, Lisa Merkl, Teresa Friedrich, et al.
European Journal of Radiology|December 3, 2020
Correlation of the apparent diffusion coefficient (ADC) and standardized uptake values (SUV) with overall survival in patients with primary non-small cell lung cancer (NSCLC) using <sup>18</sup>F-FDG PET/MRINils Martin Bruckmann, Julian Kirchner, Johannes Grueneisen, et al.
Oncotargets and Therapy|June 13, 2014
Positron emission tomographic monitoring of dual phosphatidylinositol-3-kinase and mTOR inhibition in anaplastic large cell lymphomaNicolas Graf, Zhoulei Li, Ken Herrmann, et al.
EJNMMI Research|July 18, 2024
[<sup>68</sup>Ga]Ga-FAPI versus 2-[<sup>18</sup>F]FDG PET/CT in patients with autoimmune thyroiditis: a case control studyKim M Pabst, Lukas Kessler, Justin Ferdinandus, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 6, 2022
An EANM position paper on advancing radiobiology for shaping the future of nuclear medicine, Jean-Pierre Pouget, Mark Konijnenberg, et al.
Pageof 73